Marc Evans


Ontology type: schema:Person     


Person Info

NAME

Marc

SURNAME

Evans

Publications in SciGraph latest 50 shown

  • 2018-12 Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink in BMC NEPHROLOGY
  • 2018-10 SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice in DIABETES THERAPY
  • 2018-10 Living with Type 2 Diabetes: Patient Commentary in Response to the Paper ‘SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice’ in DIABETES THERAPY
  • 2018-10 Cost-Effectiveness of Insulin Degludec vs. Insulin Glargine U100 in Type 1 and Type 2 Diabetes Mellitus in a UK Setting in DIABETES THERAPY
  • 2018-02 Factors that may Account for Cardiovascular Risk Reduction with a Dipeptidyl Peptidase-4 Inhibitor, Vildagliptin, in Young Patients with Type 2 Diabetes Mellitus in DIABETES THERAPY
  • 2017-10 Cost of Glycemic Target Achievement with Sodium Glucose Co-transporter 2 Inhibitors in Patients with Type 2 Diabetes in the UK in DIABETES THERAPY
  • 2017-05 Action on diabetic macular oedema: achieving optimal patient management in treating visual impairment due to diabetic eye disease in EYE
  • 2017-04 Cost-effectiveness of Insulin Degludec Versus Insulin Glargine in Adults with Type 1 and Type 2 Diabetes Mellitus in DIABETES THERAPY
  • 2016-12 Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Biphasic Insulin Aspart in Patients with Type 2 Diabetes from a Danish Health-Care Perspective in DIABETES THERAPY
  • 2016-09 Practical Approaches to Diabetes Care: An Introduction in DIABETES THERAPY
  • 2015-12 Factors Predictive of Weight Gain and Implications for Modeling in Type 2 Diabetes Patients Initiating Metformin and Sulfonylurea Combination Therapy in DIABETES THERAPY
  • 2015-03 Is There Evidence of Any Safety Differences Among DPP-4 Inhibitors in the Treatment of People with Type 2 Diabetes Mellitus and Reduced GFR Due to Chronic Kidney Disease? in DIABETES THERAPY
  • 2014-12 Increased Risk of Severe Hypoglycemic Events with Increasing Frequency of Non-severe Hypoglycemic Events in Patients with Type 1 and Type 2 Diabetes in DIABETES THERAPY
  • 2014-08 Lixisenatide Treatment for Older Patients with Type 2 Diabetes Mellitus Uncontrolled on Oral Antidiabetics: Meta-Analysis of Five Randomized Controlled Trials in ADVANCES IN THERAPY
  • 2013-12 Health-related quality of life associated with daytime and nocturnal hypoglycaemic events: a time trade-off survey in five countries in HEALTH AND QUALITY OF LIFE OUTCOMES
  • 2013-06 A Retrospective, Case-Note Survey of Type 2 Diabetes Patients Prescribed Incretin-Based Therapies in Clinical Practice in DIABETES THERAPY
  • 2013-06 Evaluation of Insulin Use and Value for Money in Type 2 Diabetes in the United Kingdom in DIABETES THERAPY
  • 2012-12 Pioglitazone in Clinical Practice: Where Are We Now? in DIABETES THERAPY
  • 2011-09 Long-term effects of insulin glargine on the risk of breast cancer in DIABETOLOGIA
  • 2010-08 Letter from the Editor in DIABETES THERAPY
  • 2006-11 A Model of Long-term Metabolic Progression of Type 2 Diabetes Mellitus for Evaluating Treatment Strategies in PHARMACOECONOMICS
  • 2006-09 The Authors’ Reply in PHARMACOECONOMICS
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "affiliation": [
          {
            "affiliation": {
              "id": "https://www.grid.ac/institutes/grid.273109.e", 
              "type": "Organization"
            }, 
            "isCurrent": true, 
            "type": "OrganizationRole"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.416025.4", 
            "type": "Organization"
          }, 
          {
            "id": "https://www.grid.ac/institutes/grid.241103.5", 
            "type": "Organization"
          }
        ], 
        "familyName": "Evans", 
        "givenName": "Marc", 
        "id": "sg:person.01167546340.80", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01167546340.80"
        ], 
        "sdDataset": "persons", 
        "sdDatePublished": "2019-03-07T15:03", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-uberresearch-data-dimensions-researchers-20181010/20181011/dim_researchers/base/researchers_749.json", 
        "type": "Person"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/person.01167546340.80'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/person.01167546340.80'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/person.01167546340.80'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/person.01167546340.80'


     




    Preview window. Press ESC to close (or click here)


    ...